Keiichi Yamamoto

5.7k total citations
252 papers, 4.0k citations indexed

About

Keiichi Yamamoto is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Keiichi Yamamoto has authored 252 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 37 papers in Cardiology and Cardiovascular Medicine and 23 papers in Cell Biology. Recurrent topics in Keiichi Yamamoto's work include Cardiomyopathy and Myosin Studies (29 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Cellular Mechanics and Interactions (14 papers). Keiichi Yamamoto is often cited by papers focused on Cardiomyopathy and Myosin Studies (29 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Cellular Mechanics and Interactions (14 papers). Keiichi Yamamoto collaborates with scholars based in Japan, United States and Germany. Keiichi Yamamoto's co-authors include Takamitsu Sekine, Tamaki Hayase, Yoshiko Yamamoto, Kohji Ito, Takeyuki Wakabayashi, Yuichi Kanaoka, Taku Kashiyama, Kazuo Sutoh, Yoshio Yamamoto and K. Ikuta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Keiichi Yamamoto

242 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichi Yamamoto Japan 36 1.5k 697 500 347 341 252 4.0k
Takayuki Fujita Japan 33 1.2k 0.9× 728 1.0× 196 0.4× 112 0.3× 295 0.9× 340 4.6k
Masahiro Ikeda Japan 38 2.4k 1.6× 467 0.7× 346 0.7× 137 0.4× 621 1.8× 230 5.2k
Shuzhen Wang China 38 2.8k 1.9× 230 0.3× 355 0.7× 255 0.7× 346 1.0× 420 6.3k
Daniela Grimm Germany 55 2.0k 1.4× 877 1.3× 544 1.1× 198 0.6× 926 2.7× 248 8.8k
Ran Zhang China 34 2.0k 1.4× 289 0.4× 232 0.5× 125 0.4× 279 0.8× 334 4.8k
Kazuhiro Kobayashi Japan 41 3.6k 2.5× 281 0.4× 536 1.1× 268 0.8× 144 0.4× 295 7.6k
Oliver Friedrich Germany 45 1.9k 1.3× 607 0.9× 487 1.0× 92 0.3× 266 0.8× 224 6.1k
Feng‐Xia Liang United States 48 4.1k 2.8× 565 0.8× 645 1.3× 186 0.5× 697 2.0× 157 7.7k
Michael J. Walsh United States 28 1.1k 0.7× 460 0.7× 282 0.6× 91 0.3× 257 0.8× 78 3.3k
Sujoy Ghosh United States 43 3.2k 2.2× 391 0.6× 781 1.6× 101 0.3× 131 0.4× 177 6.0k

Countries citing papers authored by Keiichi Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Keiichi Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichi Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichi Yamamoto more than expected).

Fields of papers citing papers by Keiichi Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichi Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichi Yamamoto. The network helps show where Keiichi Yamamoto may publish in the future.

Co-authorship network of co-authors of Keiichi Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichi Yamamoto. A scholar is included among the top collaborators of Keiichi Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichi Yamamoto. Keiichi Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Yoshinori, Yuji Ishii, Keiichi Yamamoto, et al.. (2024). Three-dimensional semiquantitative evaluation of reactive emphysema in magnesium implant models. Minimally Invasive Therapy & Allied Technologies. 34(2). 136–143.
2.
Matsuzaki, Keiichi, Keiichi Yamamoto, Takumi Imai, et al.. (2023). A Pragmatic Method to Integrate Data From Preexisting Cohort Studies Using the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model: Case Study. JMIR Medical Informatics. 11. e46725–e46725. 1 indexed citations
3.
Ebina, Kosuke, Tôru Hirano, Yuichi Maeda, et al.. (2021). Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study. Clinical Rheumatology. 40(7). 2673–2680. 16 indexed citations
4.
Mizusaki, Masanobu, et al.. (2021). Single and Tandem OLED Display Technologies with High Efficiency and Long Lifetime. 45(20). 13–16. 1 indexed citations
5.
Nitta, Kosaku, Masanori Abe, Ikuto Masakane, et al.. (2020). Annual dialysis data report 2018, JSDT Renal Data Registry: dialysis fluid quality, hemodialysis and hemodiafiltration, peritoneal dialysis, and diabetes. Renal Replacement Therapy. 6(1). 30 indexed citations
6.
Yamamoto, Keiichi, Tomonari Shimamoto, Keiichi Matsuzaki, et al.. (2020). Health Observation App for COVID-19 Symptom Tracking Integrated With Personal Health Records: Proof of Concept and Practical Use Study. JMIR mhealth and uhealth. 8(7). e19902–e19902. 37 indexed citations
7.
Ebina, Kosuke, Tôru Hirano, Yuichi Maeda, et al.. (2020). Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-. Clinical Rheumatology. 39(9). 2563–2572. 14 indexed citations
8.
Ebina, Kosuke, Motomu Hashimoto, Wataru Yamamoto, et al.. (2019). Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study. Arthritis Research & Therapy. 21(1). 91–91. 39 indexed citations
9.
Yamamoto, Keiichi, Eriko Sumi, Tōru Yamazaki, et al.. (2012). A pragmatic method for electronic medical record-based observational studies: developing an electronic medical records retrieval system for clinical research. BMJ Open. 2(6). e001622–e001622. 16 indexed citations
10.
Ito, Kohji, et al.. (2007). Enzymatic Activity and Motility of Recombinant Arabidopsis Myosin XI, MYA1. Plant and Cell Physiology. 48(6). 886–891. 23 indexed citations
11.
Yamamoto, Keiichi, Shigemi Matsumoto, Harue Tada, et al.. (2007). Development of Data Capture System for Clinical Study by the Secondary Use of Electronic Health Records. 2212. 2 indexed citations
12.
Iwata, Y., Keiichi Yamamoto, Hiroshi Tsutsui, et al.. (2006). Alternating phase focused IH-DTL for heavy-ion medical accelerators. Prepared for. 2328–2330. 2 indexed citations
13.
Watanabe, Kyoko, et al.. (2006). A Computer Aided Instruction for Electronic Patient Records in a Hospital. Medical Informatics. 25(4). 249–255. 1 indexed citations
14.
Saitô, Hideo, et al.. (2005). Estimation of FOE Without Optical Flow for Vehicle Lateral Position Detection. 406–409. 7 indexed citations
15.
Yamamoto, Keiichi, Shigeru Miyazaki, Hiroshi Asano, et al.. (2003). Characteristics of Specifications of Transportable Inverter-type X-ray Equipment. Japanese Journal of Radiological Technology. 59(7). 857–863.
16.
Takahashi, Kumiko, Yasuharu Noishiki, Yoshihisa YAMANE, et al.. (1994). Cardiac surgery in small dogs; our special procedure for chronic study using a new cardiopulmonary bypass system. 23(1). 342–345. 3 indexed citations
18.
Nakai, Shoji, et al.. (1990). Biliary and Urinary Metabolites of Liquiritin in Rats. 44(4). 265–268. 4 indexed citations
19.
Sato, Hirofumi, et al.. (1983). A case of afferent loop obstruction presenting as obstructive jaundice. 80(5). 1208–1211. 1 indexed citations
20.
Sato, Hirofumi, et al.. (1977). Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(11). 4101–3. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026